BIMINI Biotech is actively looking for partnerships to in-license early stage high-riksk/high-reward technologies in order to bring together novel products to patients. As such, we de-risk the early development of novel drug targets and compounds for academia and pharma. We aim to build a pipeline of highly promising leads, and eventually get more therapeutics on the market for the current unmet medical needs.